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Objectives: KPC-producing Enterobacteriaceae were first seen in the UK in 2003 and have been 21 
increasingly reported since 2010, largely owing to an ongoing outbreak in North-West England. We 22 
examined the role of clonal spread and plasmid transmission in their emergence. 23 
Methods: Isolates comprised KPC-positive Klebsiella pneumoniae (n=33), Escherichia coli (n=7) and 24 
Enterobacter spp. (n=4) referred to the national reference laboratory between 2008 and 2010 from 17 25 
UK centres, including three in North-West England. Isolates were typed by MLST. Plasmids were 26 
transferred by electroporation and characterised by PCR or sequencing. PCR screening assays were 27 
developed to distinguish plasmid pKpQIL variants. 28 
Results: The K. pneumoniae isolates included 10 STs, of which three belonged to clonal group (CG) 258. 29 
CG258 (n=19) isolates were detected in 13 centres but accounted for only 7/19 (36.8%) of those from 30 
North-West England. Most KPC-producers (37/44, 84.1%), including 16/19 CG258 K. pneumoniae carried 31 
blaKPC on IncFIIK2 plasmids. Sequencing of a subset of these plasmids (n=11) revealed similarities with 32 
published pKpQIL. One variant, pKpQIL-UK - identified in K. pneumoniae CG258 (n=5) and ST468 (n=1) 33 
isolates from distinct centres - had only a few nucleotide changes from classical pKpQIL, whereas 34 
pKpQIL-D1 (n=1) and pKpQIL-D2 (n=4), from isolates of various species in the North-West, harboured 35 
large variations reflecting replacement of the partitioning and replication functions and potentially 36 
thereby facilitating spread.  PCR revealed that 36/37 (97.3%) IncFIIK2-type plasmids in KPC-positive 37 
isolates had pKpQIL markers. 38 
Conclusions: pKpQIL-like plasmids played a major role in the early dissemination of KPC enzymes in the 39 
UK. 40 
41 
Introduction 42 
KPC (Klebsiella pneumoniae carbapenemase) enzymes are geographically widespread and increasingly 43 
prevalent.1, 2 The family includes 23 variants (KPC-2 to KPC-24), with KPC-2 and KPC-3 being globally 44 
predominant. They are mainly associated with K. pneumoniae, and in particular with the ST258 lineage, 45 
although production by other Enterobacteriaceae, Pseudomonas and Acinetobacter spp. is increasingly 46 
reported.3-8 K. pneumoniae with KPC enzymes have been endemic in the United States since the late 47 
1990s with later, dramatic, spread in e.g. Israel, Greece and Italy.9-13 The first KPC enzyme identified in 48 
the UK was KPC-4, found in 2003 in an Enterobacter cloacae complex isolate from Scotland.14 Since then, 49 
KPC-positive organisms have been occasionally reported in various part of the country, with the first 50 
KPC-carrying ST258 K. pneumoniae isolate from Scotland in 2007.15 Numbers of KPC-positive isolates 51 
rose substantially from 2010, largely due to an outbreak centred on the Greater Manchester area in 52 
North-West England.16 This outbreak remains ongoing six years later. In contrast to most international 53 
KPC problems, which are largely associated with the ST258 K. pneumoniae clone, the North West 54 
England outbreak is unusual in being polyclonal: its KPC-positive K. pneumoniae isolates have diverse 55 
PFGE profiles and belong to multiple MLST types and the 'outbreak’ also includes KPC-positive isolates 56 
belonging to other Enterobacteriaceae species, principally Enterobacter spp. and Escherichia coli.1 K. 57 
pneumoniae clonal group (CG) 258 is dominant among KPC-positive isolates from elsewhere in the UK.17  58 
The first fully-sequenced plasmid encoding a KPC enzyme was pKpQIL, a self-conjugative IncFIIK2 59 
replicon type element from a K. pneumoniae ST258 isolate collected in Israel.18 Later studies have 60 
suggested a major role for pKpQIL-like plasmids in the dissemination of KPC enzymes in Israel, Italy, 61 
Greece and the United States.19-21  62 
In this study, 44 KPC-positive isolates referred to PHE’s Antimicrobial Resistance and Healthcare 63 
Associated Infections (AMRHAI) Reference Unit in the early spread (2008-2010) of KPC enzymes in the 64 
UK were investigated, to examine the role of pKpQIL-like plasmids in their emergence. 65 
 66 
Materials and Methods 67 
Clinical isolates and transformants 68 
Isolates (n=44) comprised KPC-positive K. pneumoniae (n=33), E. coli (n=7) and Enterobacter spp. (n=4) 69 
referred to PHE’s AMRHAI Reference Unit between 2008 and 2010 from 17 centres in the UK, including 70 
three in the Greater Manchester area (Table 1). They comprised 19 of 27 geographically scattered 71 
isolates examined by the Unit between 2008 and 2010 and 25 representatives (out of the 214 referred) 72 
from the start of the North-West England outbreak, all collected in 2010. Plasmids were extracted by an 73 
alkaline lysis method and were transferred by electroporation into E. coli α-Select Strain (Bioline, 74 
London, UK) using a GenePulser electroporator (Bio-Rad, Hemel Hempstead, UK). Transformants were 75 
selected on Luria-Bertani agar supplemented with 1 mg/L ertapenem. 76 
 77 
Antimicrobial susceptibility testing and molecular characterisation of KPC-producing isolates 78 
MICs were determined by BSAC agar dilution22 and with results interpreted according to EUCAST 79 
guidelines (http://www.eucast.org/clinical_breakpoints). Conventional MLST was performed as detailed 80 
in the K. pneumoniae MLST website (http://bigsdb.pasteur.fr/klebsiella/klebsiella.html). The blaKPC gene 81 
and its direct environment were amplified as previously described23 and sequenced using an ABI Genetic 82 
Analyser capillary platform 3130XL (Applied Biosystems, CA, USA). Plasmids were classified using PCR-83 
based replicon typing (PBRT);24 IncFII replicons were sub-grouped by replicon sequence typing (RST).25 84 
Plasmid sequencing and bioinformatics analyses 85 
The complete DNA sequences of 11 KPC-encoding plasmids from isolates randomly selected to 86 
proportionally represent the distribution of isolates from the outbreak (6/25, 24%) and other UK regions 87 
(5/19, 26%), were obtained using a 454-Genome Sequencer FLX (Roche, Branford, CT, USA) on libraries 88 
generated using plasmid DNA purified from E. coli α-select transformants according to the standard 89 
protocol for whole-genome shotgun sequencing, producing 250-bp reads. A draft assembly was 90 
produced de novo with Newbler 2.6 (Roche, Branford, CT, USA); plasmid sequences were further 91 
cleaned from residual genomic contigs by in-silico subtraction of the host E. coli published genome 92 
sequences (E. coli str. K12 substr. DH10B, Genbank CP000948). 93 
Based on BLAST homologies, the published sequence of the archetypal pKpQIL plasmid 94 
(NC_014016) was used as a reference to identify nucleotide variations with Newbler 2.6. Single 95 
nucleotide polymorphisms (SNPs) and indels were inspected manually and those located in regions of 96 
homopolymers consisting of more than six units were excluded from the analysis. The MAUVE program 97 
(http://darlinglab.org/mauve/mauve.html) was used to re-order assembled contigs according to the 98 
pKpQIL sequence. Remaining gaps were closed by standard PCR and sequencing using manually-99 
designed primers. Coding sequences were identified using Glimmer 2.13 100 
(http://www.cs.jhu.edu/~genomics/Glimmer/) and gene functions were inferred based on homology 101 
searches with BLAST. Sequence homologies with published plasmids were checked by BLAST using the 102 
Blast Ring Image Generator (BRIG) software.26 The reference plasmids included (i) pKpQIL (GenBank 103 
NC_014016), pGR-1504 (KF874496), pIT-01C03 (HG969995), pKp41 (CP012000), pKpQIL-10 (KJ146687), 104 
pKpQIL-531 (CP008833), pKpQIL-6e6 (CP014650), pUHKPC07 (CP011986), pUHKPC33 (CP011991), pG12-105 
KPC2 (KU665642), pIT-01C22 (HG969997), pKpQIL-IT (JN233705), pGR-1870 (KF874498), 106 
pKPN207_p2(LT216438) and pIT-11C07 (HG969998)  all of which were previously reported from CG258 107 
K. pneumoniae isolates, (ii) pGR-3913 (KF874499), pKpQIL-9b8 (CP014765), pGR-1780 (KF874497) and 108 
pKpQIL-234 (KJ146689) which were variously reported from K. pneumoniae isolates belonging to ST35, 109 
ST37, ST147 and ST234, respectively, and (iii) pBK33689 (KU295133), pKpQIL-571 (CP014669) and 110 
pKpQIL-Ec  (KJ146688), all of which were reported from E. coli. 111 
The complete nucleotide sequences of plasmids pKpQIL-UK, pKpQIL-D1 and pKpQIL-D2 112 
generated in this study were submitted to GenBank under the accession numbers KY798507, KY798505 113 
and KY798506, respectively. 114 
 115 
Detection of pKpQIL-like IncFIIK2 plasmids by PCR 116 
PCR primers were designed to amplify size-distinguishable fragments from six markers on pKpQIL-like 117 
backbones; these markers were selected based on the comparison of available plasmid sequences 118 
(Table 2). They covered four distinct regions of the pKpQIL-backbone, comprising (i) both the traI and 119 
traK genes encoding the transfer-conjugation functions, (ii) the blaKPC carbapenemase gene, and (iii) a 120 
gene encoding a conserved hypothetical protein (Table 1). Primers targeting parB of pKpQIL and its 121 
homologue in pKpQIL-D2 were added to differentiate between these two plasmid variants. The 50S 122 
ribosomal protein gene rplQ was targeted as an internal PCR control from a chromosomal region 123 
conserved among Enterobacteriaceae (Table 2). 124 
Amplification mixtures contained each of the primers described in Table 2 at a final 125 
concentration of 0.2 μM and were performed with the following cycling conditions: 95°C for 5 min, 30 126 
cycles of 95°C for 30 s, 55°C for 30 s and 72°C for 30 s and one final cycle at 72°C for 5 min. 127 
128 
Results 129 
Characteristics of the KPC producers 130 
Thirty-three of the 44 KPC producers including 24 K. pneumoniae, seven E. coli and two Enterobacter 131 
spp. harboured blaKPC-2 whereas nine K. pneumoniae had blaKPC-3 and two Enterobacter spp. carried 132 
blaKPC-4.  Almost all (41/44, 93.2%) of the KPC-encoding genes were embedded in Tn4401 isoform ‘a’ 133 
transposons, predominantly on IncFIIK2 replicon-type plasmids (n=37), although some were carried on 134 
IncFIIK1 (n=1), IncFIIK5 (n=1) or non-typable (n=2) plasmids. Of the remainder, genes encoding KPC-3 (n=1) 135 
or KPC-4 (n=2) enzymes were located within Tn4401 isoform ‘b’ transposons on non-typable plasmids. 136 
Among 27 isolates from North-West England, only four (14.8%) had their blaKPC gene on non-IncFIIK2 137 
plasmids; these comprised three K. pneumoniae and one E. coli carrying the gene on IncFIIK5 or non-138 
typable plasmids. 139 
The 33 K. pneumoniae isolates included 10 STs, with 19 isolates belonging to the clonal group 140 
(CG) 258 and comprising ST258 (n=15), ST11 (n=3) and ST512 (n=1) (Table 1). Non-CG258 STs (n=14) 141 
comprised ST321, with eight representatives mainly (6/8, 75%) from North-West England, as well as 142 
ST25, ST27, ST248, ST468, ST490 and ST491 each represented by a single isolate (Table 1). CG258 was 143 
widespread, being identified in 13 different centres across the UK. It dominated among K. pneumoniae 144 
isolates (12/14, 85.7%) recovered outside North-West England. By contrast K. pneumoniae isolates 145 
(n=19) from North-West England were diverse and belonged to nine different STs, with CG258 (7/19, 146 
36.8%) and ST321 (6/19, 31.6%) the most represented (Table 1). 147 
Antibiotic susceptibility testing showed that the majority of the KPC-producers were resistant to 148 
all β-lactams (88.6%) with the exception of five isolates recovered outside the North-West region 149 
showing susceptibility to meropenem, alone (n=4) or to both meropenem and imipenem (n=1). In 150 
contrast, isolates remained mostly susceptible to colistin (88.6%) and variably susceptible to amikacin 151 
(70.5%), gentamicin (68.2%), ciprofloxacin (38.6%) and tigecycline (65.9%), with no marked regional 152 
differences in susceptibility frequencies. Colistin resistance was detected in only five K. pneumoniae 153 
isolates, including three from North-West England (Table 3). 154 
 155 
The structure of KPC-encoding IncFIIK2 plasmids  156 
The presence of IncFIIK2 plasmids among diverse STs of KPC-positive K. pneumoniae, as well as E. coli and 157 
Enterobacter spp. suggested that these were playing a major role in the early dissemination of KPC 158 
enzymes in the UK. Therefore, 11 IncFIIK2 plasmids originating from K. pneumoniae (n=9), Escherichia coli 159 
(n=1) and Enterobacter spp. (n=1) from the North-West outbreak and five other UK centres were fully 160 
sequenced (Table 1). 161 
Plasmids, designated pKpQIL-UK, from K. pneumoniae ST486 isolate L33 (North-West England) 162 
and CG258 isolates T4, T6, T8, T13 and T27 (from centres outside North West England), were nearly 163 
identical to the archetypal IncFIIK2 KPC plasmid pKpQIL.  At most, these plasmids were distinguished by 164 
32 nucleotide variations (Figure 1A) and, of these, 22 were confined in a single non-coding region of 100 165 
bp (positions 5270 to 5370 of pKpQIL) and were observed in plasmid T8 only. Based on the published 166 
annotation of pKpQIL, eight other variations found in the present plasmids were located in non-coding 167 
regions or were synonymous, having no effect on the amino acid sequences of the inferred gene 168 
products. A more significant variation was that all the plasmids from CG258 variants had a 1-bp deletion, 169 
creating a translational shift in a region predicted to encode a 130 aa hypothetical protein (positions 170 
86406 to 86795 pKpQIL); the plasmids from CG258 isolates T4, T8 and L33 also had a substitution in the 171 
coding region of blaKPC, changing KPC-3 to a KPC-2 enzyme. 172 
The remaining five IncFIIK2 plasmids, from isolates L27, L38, T19, LESC and LENT, all from the 173 
North-West England outbreak, harboured large DNA fragment substitutions. The remaining portions of 174 
these plasmids, representing 86.8% of the total length of plasmid T19 and 84.2% of the four other 175 
derived plasmids remained almost identical to pKpQIL with at most 25 nucleotide variations to 176 
distinguish them. Of these variations, eight, including mutations in the KPC-encoding gene, were 177 
identical to those observed in the pKpQIL-UK variant suggesting that plasmids pKpQIL-UK, -D1 and -D2 178 
have evolved from the same ancestor. 179 
The T19 plasmid, named pKpQIL-D1 (117,903 bp), which originated from an ST11 K. pneumoniae 180 
isolate, had the 11,260 bp fragment (positions 25,539 to 36,799 of pKpQIL) located between the 181 
insertion sequence IS26 and the resolvase and carrying blaTEM-1, truncated blaOXA-9, mercuric resistance 182 
genes and the vagCD addiction system genes replaced by a 15,524 bp fragment encoding 14 ORFs 183 
comprising IS66, truncated IS4321R, Tn3 transposase, resolvase and nine hypothetical proteins of which 184 
three showed low homologies to endonuclease, Na+/H+ antiporter and DNA binding proteins (Figure 1). 185 
The plasmids from K. pneumoniae isolates L27 and L38, from E. coli LESC and Enterobacter LENT 186 
were similar to each other and were designated pKpQIL-D2 (111,742 bp). This plasmid shared the 187 
pKpQIL regions from 1 to 36,830 bp and from 56350 to 113,637 bp, but had the 19,520 bp fragment 188 
located between the addiction operon vagCD and the plasmid stability stbA gene replaced by a 17,625-189 
bp fragment harbouring 19 genes (Figure 1). Although markedly different at the sequence level, some of 190 
the replacement genes encoded proteins homologous to those determined by the deleted pKpQIL 191 
fragment, such as the UmuC and UmuD SOS mutagenesis and repair proteins, the ParA and ParB 192 
plasmid-partitioning proteins and an origin of replication RepB (Figure 1B). Interestingly, the ‘new’ 193 
portion, encoding the plasmid-partitioning genes, has been described in other plasmid sequences 194 
deposited in the GenBank database and originating from various Enterobacteriaceae genera including 195 
Klebsiella (KP008371), Salmonella (CP006054), Escherichia (KT845955), Providencia (JQ824049), 196 
Enterobacter (CP011587) and Proteus (CP015347). This degree of dissemination suggests that ParA and 197 
ParB, as encoded by pKpQIL-D2, may favour stable plasmid maintenance in diverse host species. 198 
Comparison of pKpQIL-like IncFIIK2 plasmids 199 
Sequences of the present pKpQIL-UK, -D1 and -D2 plasmids were compared with similar (≥ 75% identity) 200 
pKpQIL-like plasmids previously reported from K. pneumoniae (n=19) and E. coli (n=3) in Greece, Italy, 201 
Norway and United States (Figure 1A). 202 
The majority (15/19) of the published plasmids from K. pneumoniae were from CG258 isolates 203 
with the four exceptions being from ST35, ST37, ST147 and ST234 organisms (Figure 1A). In 11/19 204 
plasmids, described from CG258 (n=8), ST35 and ST147 isolates of various origins, differences were 205 
limited to a few nucleotide variations from the archetypal pKpQIL, and were similar to those identified in 206 
this study. The remaining eight plasmids, of which six were from CG258 isolates, had various genetic 207 
rearrangements including insertions or deletions of insertion sequences resulting in the acquisition of 208 
genes encoding mainly resistance genes, as well as inversions or substitutions in pKpQIL portions 209 
carrying genes encoding the partitioning, transfer and conjugal activities, similar to those identified here 210 
in pKpQIL-D2 (Figure 1A). The detection of plasmids almost identical to pKpQIL in non-CG258 isolates, (i) 211 
as in the case of published plasmids pGR-3913 (ST35)21 and pGR-1780 (ST147)21 and (ii) as with pKpQIL-212 
UK (ST486) here, indicates that these plasmids have the potential to spread among distinct K. 213 
pneumoniae lineages. 214 
In contrast to the dominance of near-classical pKpQIL in K. pneumoniae, all the published 215 
pKpQIL-like plasmids from E. coli, and those sequenced here, had major modifications in their 216 
backbones. Like the pKpQIL-D1 present, both pKpQIL-Ec and pKPQIL-571 plasmids (originally described 217 
from E. coli isolates in the United States)20 had deletions in the pKpQIL region located between the IS26 218 
element and genes encoding the restriction endonuclease units (Figure 1A). On the other hand, plasmid 219 
pBK33689 (KU295133), also described in United States, had the 5.5-kb region located upstream of the 220 
repA gene substituted by a fragment carrying among others a gene encoding an additional replication 221 
protein RepB (Figure 1A). 222 
 223 
Distribution of pKpQIL-like plasmids in the UK 224 
The screening assay for pKpQIL-like plasmids was validated on the 11 isolates harbouring the fully 225 
sequenced KPC plasmids. As expected, all isolates amplified the pKpQIL-markers traI, traK, hyp and 226 
blaKPC whilst the banding pattern of parB varied according to whether pKpQIL or pKPQIL-D2 was present 227 
(Table 1). The assay was then applied to the remaining (n=26) KPC-positive clinical isolates that had been 228 
shown to carry IncFIIK2 plasmids by PCR-based replicon typing but where sequencing had not been 229 
performed. Nearly all (25/26, 96%) yielded the traI, traK, hyp and the blaKPC fragments. Of these, 21 230 
amplified also the partitioning parB fragments of either pKpQIL (n=15), or pKpQIL-D2 (n=6) while four 231 
had neither (Table 1). Only one isolate failed to amplify any pKpQIL-marker and yielded the fragments of 232 
only blaKPC and the rplQ internal control, suggesting that the KPC gene is harboured on an IncFIIK2 233 
plasmid distinct from pKpQIL. Overall, the assay inferred the presence of pKpQIL-like plasmids in seven 234 
K. pneumoniae STs and pKpQIL-D2 in three STs; only the most represented CG258 and ST321 lineages 235 
were associated with both variants. 236 
This screening supports the view that pKpQIL plasmids were disseminating in the UK in the 237 
2008-10 study period and suggests considerably plasticity in the region carrying their partitioning 238 
functions. The assay showed that only two of the five E. coli isolates carried the parB of pKpQIL-D2 and 239 
all four isolates failing to amplify any parB fragments belonged to K. pneumoniae. Although no clear 240 
association was found between species and amplification of the plasmid-partitioning gene types carried, 241 
the presence of other types of modifications that could potentially affect the replication or segregation 242 
of these plasmids cannot be excluded, particularly in those plasmids profiled only by PCR and not by 243 
sequencing 244 
245 
Discussion 246 
Our analysis revealed that IncFIIK2 pKpQIL-like elements played a major role in the early (2008-10) spread 247 
of KPC carbapenemases among diverse Enterobacteriaceae species in the UK. Plasmids related to 248 
archetypal IncFIIK2 pKpQIL were identified in 36/37 isolates carrying an IncFIIK2 replicon type and in 249 
81.2% (36/44) of all KPC-bearing isolates included in this study. 250 
Sequencing identified plasmids (designated pKpQIL-UK) that were nearly identical to each other 251 
and to published pKpQIL from K. pneumoniae isolates belonging to CG258 and ST468 from distinct UK 252 
centres, including in North-West England. Screening for pKpQIL markers inferred the presence of these 253 
classical forms of pKpQIL in K. pneumoniae isolates belonging to four other STs (e.g. ST25, 248, 321 and 254 
491) among those identified in this study. Published plasmid sequences from non-CG258 isolates,20, 21 255 
and those reported in this study clearly suggest that highly conserved pKpQIL plasmids, although mainly 256 
associated with CG258, are able to spread among other lineages of K. pneumoniae. 257 
Plasmids with large DNA fragment replacements in their pKpQIL-backbone were identified from 258 
the North-West England outbreak only. Critically, though, they were found not only in K. pneumoniae 259 
isolates, but also in Enterobacter spp. and E. coli. One variant, pKpQIL-D2, had lost a 19.5-kb DNA 260 
fragment of pKpQIL that carries genes encoding the plasmid partitioning and replication functions and 261 
had this replaced with a 17.6-kb fragment partly encoding similar functions. In contrast to the original 262 
parAB genes of pKpQIL, which seem to be confined to K. pneumoniae, the variants present in pKpQIL-D2 263 
have been described previously in plasmids from various Enterobacteriaceae species and might favour 264 
the stable inheritance of this variant plasmid across diverse species.  265 
A further variant plasmid, termed pKpQIL-D1, was identified in a single K. pneumoniae isolate, 266 
from North-West England and had the 11.2-kb DNA fragment of pKpQIL harbouring the antimicrobial 267 
and mercury resistance genes and the plasmid maintenance system VagCD substituted. Interestingly, 268 
the fully-sequenced plasmids pKpQIL-Ec (KJ146688) and pKpQIL-571 (CP014669) from E. coli and pKpQIL-269 
98b (CP014765) from K. pneumoniae, both recently described in the United States, harboured deletions 270 
located in the same region substituted in pKpQIL-D1. The system vagCD is thought to help plasmid 271 
maintenance by preventing the cell division until plasmid replication is complete.27 The loss of the 272 
plasmid maintenance system in these pKpQIL-derivatives may have increased the chances of being 273 
acquired by hosts in which their replication may be less efficient. 274 
Comparison of published pKpQIL-like sequences with those generated in this study showed that 275 
the pKpQIL-region between the IS26 element and the genes encoding UmuCD are the most affected by 276 
modifications. The identification of isolates failing to amplify any of the parB genes sought in the 277 
screening assay for pKpQIL markers developed in this study further supports the inference of high 278 
plasticity in this region. 279 
Overall, these results showed that CG258 K. pneumoniae with conserved pKpQIL-like plasmids 280 
played a major role in the early spread of KPC enzymes in multiple regions of the UK. Their distribution 281 
among further K. pneumoniae STs shows that these relatively conserved pKpQIL plasmids can spread 282 
among lineages of this species.  We postulate that, in North-West England they evolved, mainly by 283 
modifications of portions encoding plasmid partitioning and replication activities. We suggest that this, 284 
in turn, facilitated their spread into various Enterobacteriaceae species, again notably in North-West 285 
England. The evolution of unusually transmissible pKpQIL-like plasmids in the early years after the first 286 
appearance of KPC enzymes in the UK could also explain the polyclonal nature of K. pneumoniae isolates 287 
from the ongoing North-West England outbreak, as compared with the international experience, where 288 
the epidemiology of KPC K. pneumoniae is dominated by CG258 K. pneumoniae variants. 289 
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Table 1. Molecular characterisation of the KPC-positive Enterobacteriaceae. 382 
Isolate Species Year ST Centre KPC  
variant 
Tn4401 
Isoform 
Replicon 
type 
pKpQIL PCR 
        parB-O KPC rplQ traK traI parB-D2 hyp interpretation 
T1 K. pneumoniae 2008 512 (CG258) A 3 a IncFIIK2 + + + + +  + pKpQIL-like 
T2 K. pneumoniae 2008 258 (CG258) B 2 a IncFIIK2 + + + + +  + pKpQIL-like 
T3 K. pneumoniae 2008 258 (CG258) C 3 a IncFIIK2 + + + + +  + pKpQIL-like 
T4 K. pneumoniae 2008 258 (CG258) D 2 a IncFIIK2 + + + + +  + pKpQIL-like 
T5 K. pneumoniae 2009 258 (CG258) E 3 a IncFIIK2 + + + + +  + pKpQIL-like 
T6 K. pneumoniae 2009 258 (CG258) F 3 a IncFIIK2 + + + + +  + pKpQIL-like 
L16 K. pneumoniae 2009 258 (CG258) NW-C2 2 a IncFIIK2  + + + +  + pKpQIL-like* 
T8 K. pneumoniae 2009 258 (CG258) G 2 a IncFIIK2 + + + + +  + pKpQIL-like 
T9 Enterobacter spp. 2009 ND H 4 b ND NT NT NT NT NT NT NT unknown 
T10 K. pneumoniae 2009 258 (CG258) I 3 a IncFIIK2 + + + + +  + pKpQIL-like 
T11 K. pneumoniae 2009 258 (CG258) NW-C3 2 a IncFIIK5 NT NT NT NT NT NT NT unknown 
T12 K. pneumoniae 2009 258 (CG258) A 3 a incFIIK2 + + + + +  + pKpQIL-like 
T13 K. pneumoniae 2009 11 (CG258) j 3 a IncFIIK2 + + + + +  + pKpQIL-like 
T14 K. pneumoniae 2010 258 (CG258) NW-C1 3 b ND NT NT NT NT NT NT NT unknown 
T15 K. pneumoniae 2010 321 E 2 a incFIIK2  + + + + + + pKpQIL-like (D2) 
T16 K. pneumoniae 2010 321 NW-C1 2 a IncFIIK2 + + + + +  + pKpQIL-like 
T17 K. pneumoniae 2010 248 NW-C1 2 a IncFIIK2 + + + + +  + pKpQIL-like 
T18 K. pneumoniae 2010 321 K 2 a IncFIIK2  + + + + + + pKpQIL-like (D2) 
T19 K. pneumoniae 2010 11 (CG258) NW-C1 2 a IncFIIK2 + + + + +  + pKpQIL-like 
T20 E. coli 2010 ND NW-C1 2 a IncFIIK2 + + + + +  + pKpQIL-like 
T21 E. coli 2010 ND NW-C1 2 a ND NT NT NT NT NT NT NT Unknown 
T22 Enterobacter spp. 2010 ND NW-C1 2 a IncFIIK2  + +     Unknown 
T23 Enterobacter spp. 2010 ND L 4 b ND NT NT NT NT NT NT NT Unknown 
T24 K. pneumoniae 2010 321 NW-C3 2 a IncFIIK2  + + + + + + pKpQIL-like (D2) 
T25 K. pneumoniae 2010 27 NW-C3 2 a ND NT NT NT NT NT NT NT Unknown 
T26 K. pneumoniae 2010 321 NW-C3 2 a IncFIIK2  + + + + + + pKpQIL-like (D2) 
T27 K. pneumoniae 2010 258 (CG258) M 2 a IncFIIK2 + + + + +  + pKpQIL-like 
T28 K. pneumoniae 2010 258 (CG258) C 3 a IncFIIK1 NT NT NT NT NT NT NT Unknown 
T29 K. pneumoniae 2010 321 NW-C1 2 a IncFIIK2 + + + + +  + pKpQIL-like 
T30 K. pneumoniae 2010 321 NW-C1 2 a IncFIIK2  + + + +  + pKpQIL-like* 
T31 E. coli 2010 ND NW-C1 2 a IncFIIK2 + + + + +  + pKpQIL-like 
T32 E. coli 2010 ND NW-C1 2 a IncFIIK2  + + + + + + pKpQIL-like (D2) 
T33 E. coli 2010 ND NW-C1 2 a IncFIIK2 + + + + +  + pKpQIL-like 
L19 K. pneumoniae 2010 258 (CG258) NW-C1 2 a IncFIIK2  + + + +  + pKpQIL-like* 
L22 K. pneumoniae 2010 11 (CG258) NW-C1 2 a IncFIIK2  + + + + + + pKpQIL-like (D2) 
L23 K. pneumoniae 2010 25 NW-C2 2 a IncFIIK2 + + + + +  + pKpQIL-like 
L27 K. pneumoniae 2010 321 NW-C1 2 a IncFIIK2  + + + + + + pKpQIL-like (D2) 
L33 K. pneumoniae 2010 468 NW-C2 2 a IncFIIK2 + + + + +  + pKpQIL-like 
L37 K. pneumoniae 2010 491 NW-C1 2 a IncFIIK2 + + + + +  + pKpQIL-like 
L38 K. pneumoniae 2010 490 NW-C1 2 a IncFIIK2  + + + + + + pKpQIL-like (D2) 
L39 K. pneumoniae 2010 258 (CG258) NW-C1 2 a IncFIIK2  + + + +  + pKpQIL-like* 
LENT Enterobacter spp. 2010 ND NW-C1 2 a IncFIIK2  + + + + + + pKpQIL-like (D2) 
LESC E. coli 2010 ND NW-C1 2 a IncFIIK2  + + + + + + pKpQIL-like (D2) 
I2 E. coli 2010 ND N 2 a IncFIIK2 + + + + +  + pKpQIL-like 
Isolates with sequenced KPC-encoding plasmids are shown in bold. (*) indicates plasmids failing to amplify any parB fragments; (ND) not 383 
determined; (NT) not tested.  Centres is North-West England have codes starting NW-C; the other centres A-N were elsewhere in the UK 384 
385 
Table 2. Primers used to seek pKpQIL-like plasmids. 386 
Target Primer Sequence Size (bp) 
hyp hyp-for  GGTCAGAAAATCACGTCTGAA 412 
 hyp-rev CTCACCGTGAATGTCATAGC  
parB-D2 parBD2-for GTAAGACCTTCGTAAACCAGGA 315 
 parBD2-rev AAGAGCGATCAATCTCAGGC  
traI traI-for TCGTTGCTCTCGTGTTTTTC 247 
 traI-Rev GGTGAAACCAGAATGACCAC  
traK traK-for CAGGCAAATATTGCCGTGAG 203 
 traK-rev GCACGAATGGAGAAGTTCAG  
rplQ IC-for ATGCGCCATCGTAAGAGTGGT 170 
 IC-rev GTCTTGGCAAGAGTAATCAGCGG  
blaKPC KPC-for GCTTGCTGGACACACCCAT 127 
 KPC-rev ATCACTGTATTGCACGGCG  
parB-O parB-for ACCTATGAATTTGCCCGTCT 91 
 parB-rev TTTCGAAGGACTGCATGTTG  
  387 
Table 3. MIC distributions for KPC producers 388 
Antibiotic Species Region Number of isolates with MIC (mg/L) % S 
   ≤ 0.5 1 2 4 8 16 ≥ 32   
Ertapenem K. pneumoniae North-West England             19 0 0 
  Other centres             14 0 
 Other spp. North-West England     1 1 2 1 3 0 
  Other centres       2b     1 0 
Imipenem K. pneumoniae North-West England         2 8 9 0 2.3 
  Other centres         1 2 11 0 
 Other spp. North-West England       2 4   2 0 
  Other centres   1   1   1   33.3 
Meropenem K. pneumoniae North-West England         3 7 9 0 11.4 
  Other centres         1  13 0 
 Other spp. North-West England   1 2 2   1 2 37.5 
  Other centres 1 1     1     66.7 
Cefotaxime K. pneumoniae North-West England         5 6 8 0 0 
  Other centres          1 13 0 
 Other spp. North-West England     1 1   2 4 0 
  Other centres             3 0 
Ceftazidime K. pneumoniae North-West England       1 2 6 10 0 0 
  Other centres         3 11 0 
 Other spp. North-West England     2 1   2 3 0 
  Other centres         1   2 0 
Amikacin K. pneumoniae North-West England  5 6 1 2  5 73.7 70.5 
  Other centres 1 1 1 1 3 1 6 50 
 Other spp. North-West England   1 3 2 2     100 
  Other centres   2         1 66.7 
Gentamicin K. pneumoniae North-West England 8 4 2  2  3 73.7 68.2 
  Other centres 2 5 2 2 2 1  64.3 
 Other spp. North-West England 2 3   2     1 62.5 
  Other centres 2           1 66.7 
Ciprofloxacin K. pneumoniae North-West England 8 1 1  1 1 7a   42.1 38.6 
  Other centres 2       12a   14.3 
 Other spp. North-West England 7         1a   87.5 
  Other centres           3a   0 
Colistin K. pneumoniae North-West England 12 4    1 2 84.2 88.6 
  Other centres 11 1   1  1 85.7 
 Other spp. North-West England 8             100 
  Other centres 3             100 
Tigecycline K. pneumoniae North-West England 6 8 5         73.7 65.9 
  Other centres 1 5 7 1       42.9 
 Other spp. North-West England 5 3           100 
  Other centres   1   1 1     33.3 
S, susceptible; cell colours showed number of isolates susceptible (white), intermediate (light-grey) and resistant (dark-grey) to each tested 389 
antibiotics according to EUCAST breakpoints. (a), showed numbers with MIC greater or equal to the indicated value, which represented the 390 
maximum concentration tested for the corresponding antibiotic, (b) indicated the ertapenem MIC of the Enterobacter cloacae isolate showing 391 
sensitivity to imipenem and meropenem.  392 
 393 
 394 
Figure 1. This figure appears in colour in the online version of JAC and in black and white in the printed version of JAC 395 
A. Sequence homologies amongst published pKpQIL-like plasmids. 396 
397 
Gene contents of the substituted DNA fragments of pKpQIL-D1 and pKpQIL-D2. 398 
 399 
 400 
(A) Coloured rings showed published plasmids from K. pneumoniae (purple), E. coli (blue) and those generated in this study (green). D1 and D2 401 
indicated the fragments of pKpQIL plasmid that were substituted in pKpQIL-D1 and pKpQIL-D2, respectively, while the pKpQIL fragment indicated I1 402 
is inversely oriented in plasmid pKpQIL-234. 403 
(B) Colours in the substituted DNA fragments showed genes encoding known functions (blue), hypothetical proteins (yellow) and mobile elements 404 
(red). Irrespective of their encoding functions, genes of pKpQIL present at the flanking regions of the two substitutions are coloured in black. 405 
  406 
Figure 1. This figure appears in colour in the online version of JAC and in black and white in the printed version of JAC 407 
A. Sequence homologies amongst published pKpQIL-like plasmids. 408 
  409 
B. Gene contents of the substituted DNA fragments of pKpQIL-D1 and pKpQIL-D2. 410 
 411 
 412 
 413 
(A) Coloured rings showed published plasmids from K. pneumoniae (light grey), E. coli (medium-dark grey) and those generated in this study (dark 414 
grey). D1 and D2 indicated the fragments of pKpQIL plasmid that were substituted in pKpQIL-D1 and pKpQIL-D2, respectively, while the pKpQIL 415 
fragment indicated I1 is inversely oriented in plasmid pKpQIL-234. 416 
(B) Colours in the substituted DNA fragments showed genes encoding known functions (grey), hypothetical proteins (white) and mobile elements 417 
(black dots). Irrespective of their encoding functions, genes of pKpQIL present at the flanking regions of the two substitutions were coloured in 418 
black. 419 
 420 
